Evidence map›Paper›PMID 36062935›Full record

ArticleThe Libyan journal of medicine2022

Variant-specific RT-qPCR for rapid screening of B.1.617 mutations in SARS-CoV-2.

Mwada Jallul, Khaled Ibrahim, Ahmed Zaghdani, Mohamed Musbah Abdusalam, Samira M Al Dwigen, Wafya S Atwair, Mohamed Elbasir, Inas Alhudiri, Salah Edin El Meshri, Adam Elzagheid

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Libyan journal of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mwada JallulGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.ORCID 0000-0001-6897-5785
Khaled IbrahimGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.
Ahmed ZaghdaniDepartment of Microbiology, Libyan Biotechnology Research Centre, Tripoli, Libya.
Mohamed Musbah AbdusalamGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.
Samira M Al DwigenDepartment of Cell Biology, Libyan Biotechnology Research Centre, Tripoli, Libya.
Wafya S AtwairGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.
Mohamed ElbasirGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.
Inas AlhudiriGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.ORCID 0000-0002-3371-0215
Salah Edin El MeshriDepartment of Microbiology, Libyan Biotechnology Research Centre, Tripoli, Libya.
Adam ElzagheidGenetic Engineering Department, Libyan Biotechnology Research Center, Tripoli, Libya.ORCID 0000-0002-7086-5937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuous emergence of new SARS-CoV-2 variants required rapid and reliable diagnostic methods for early detection and monitoring of the spread of the virus, especially in low-resource countries where whole genome sequencing is not available. We aimed to evaluate and compare the performance of two different RT-qPCR screening assays for the detection of B.1.617 lineage mutations. A total of 85 SARS-CoV-2 positive samples were collected between 9

Indexed as

COVID-19SARS-CoV-2HumansMutationPolymerase Chain ReactionB.1.617 lineagedelta variantkappa variantLibyaRT- qPCR

Identifiers

PMID36062935
PMCPMC9467536
OpenAlexW4294668220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.